Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Methylene blue has certain advantages over isosulfan blue in sentinel lymph node procedures, but the risk of a palpable mass at the injection…
NEW YORK (Reuters Health) – Adult patients with asthma exacerbations do as well with 2 days of oral dexamethasone as with 5 days of oral prednisone, according to…
NEW YORK (Reuters Health) – Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron…
NEW YORK (Reuters Health) – While carotid artery stenting (CAS) can be performed safely in different hospital settings by a variety of specialists, both site and operator volumes…
NEW YORK (Reuters Health) – Despite the fact that methicillin-resistant Staphylococcus aureus (MRSA) is usually isolated nowadays from purulent skin and soft tissue infections in children, treatment with…
NEW YORK (Reuters Health) – Patients with sirolimus-eluting stent (SES) restenosis may be better managed with balloon angioplasty using a paclitaxel-coated balloon (PEB) catheter rather than conventional balloon…
NEW YORK (Reuters Health) – A “focused update” to existing guidelines on the management of patients with atrial fibrillation (AF) states that the recently approved oral direct thrombin…
NEW YORK (Reuters Health) – Simple tests performed during an office visit can help identify who can safely drive after a stroke, investigators from Belgium and the US…
NEW YORK (Reuters Health) – Patients with type 2 diabetes have better glycemic control and less nausea when exenatide is given weekly rather than twice daily, according to…
NEW YORK (Reuters Health) – Using paclitaxel-eluting stents to treat saphenous vein graft (SVG) lesions is associated with better outcomes than is the use of bare metal stents,…
